Your trusted source for investing success
Trump’s policies are affecting gold. You should know what’s going on. Click here to get our FREE report.
Click here to get your free report!Discover what the experts see coming in the Age of Trump with our INN Insider's Report free of charge! Includes expert insights into Trump and his effect on mining and gold.
Valens GroWorks Corp. (CSE:VGW) (the “Company” or “Valens”) is pleased to announce the exercise of 322,221 warrants at a price of $0.75 per share, resulting in the issue of 322,221 common shares of the Company. This provides $41,666 cash added to the Company’s treasury, and a $200,000 reduction in payables.
By Micha Boon
Valens GroWorks Corp. (CSE:VGW) (“Valens GroWorks”, or the “Company”) is pleased to announce that its wholly owned subsidiary Valens Agritech Ltd. (“Valens”), a Health Canada Licensed Dealer, has signed a supply and sales agreement with Canopy Growth Corporation (TSX: WEED) (“Canopy Growth”) for the distribution, marketing and sale of the
By Micha Boon
Valens GroWorks Corp (CSE:VGW) (the “Company”) is pleased to announce a research partnership with UBC Okanagan and Thompson Rivers University. Dubbed the Cannabis Bio-products Toolbox, this collaborative research project will explore the vast range of bioproducts that can be made from the plant – these include pharmaceuticals, nutritional products, and
By Shelly Kumar
Valens GroWorks (CSE:VGW)(CSE:VGW.CN) (the “Company” or “Valens“), a vertically integrated provider of cannabis products, is pleased to announce the closing of an additional 85,000 units (the “Units”) for proceeds of $85,000, the final tranche of its non-brokered $1.00 per Unit private placement (the “Offering”) first announced on July 26, 2017. The Offering
By Shelly Kumar
Valens GroWorks (CSE:VGW)(CSE:VGW.CN) (the “Company” or “Valens“) is pleased to announce the exercise of 622,221 warrants at a price of $0.75 per share, resulting in the issue of 622,221 common shares (“Shares”) of the Company. This provides $393,000 cash added to the Company’s treasury, a $49,857 reduction in payables, and $23,476 in
By Shelly Kumar
Valens GroWorks (CSE:VGW)(CSE:VGW.CN) (the “Company” or “Valens“) and its wholly-owned subsidiary Supra THC Services Inc. (“Supra”) are pleased to announce a collaboration between Supra and Thermo Fisher Scientific (Mississauga) Inc. to develop a “Centre of Excellence in Plant Based Medicine Analytics” centered in Kelowna, British Columbia. This agreement is the first of
By Shelly Kumar
Valens GroWorks (CSE:VGW)(CSE:VGW.CN) (the “Company” or “Valens“), a vertically integrated provider of cannabis products, is pleased to announce it is closing 3,250,615 units (the “Units”) for proceeds of $3,250,615, the first tranche of its non-brokered private placement to raise up to $4,000,000 at a price of $1.00 per Unit (the “Offering”), as
By Shelly Kumar
Valens GroWorks (CSE:VGW)(CSE:VGW.CN) (the “Company” or “Valens“), a vertically integrated provider of cannabis products, is pleased to announce a non-brokered private placement of up to 4,000,000 units (the “Units”) at a price of $1.00 per Unit for gross proceeds of up to $4,000,000 (the “Offering”).
The net proceeds of the Offering will be
By Shelly Kumar
Valens GroWorks (CSE:VGW)(CSE:VGW.CN) (the “Company” or “Valens“) is pleased to announce that Mr. Saul Katz has joined the Company as its President.
Mr. Katz brings to Valens 35 years of entrepreneurship, senior management experience and scientific expertise in functional food product development and commercialization. Over his career he established research collaborations with leading
Valens GroWorks (CSE:VGW)(CSE:VGW.CN) (the “Company” or “Valens“) announces the resignation of Mr. Mark Doucet. Mr. Doucet was appointed President of the Company as announced on March 14, 2017. The Stock Options granted to Mr. Doucet in accordance with the Company’s stock option plan have been cancelled.
About Valens GroWorks Corp.
Valens GroWorks Corp is
Aurora Cannabis and Radient Technologies completed their joint research into whether Radient’s proprietary MAP technology and an “associated continuous flow design” extracting cannabinoids.
By Pia Rivera
Valens GroWorks Corp. (CSE:VGW)(CSE:VGW.CN) (with its 100%-owned subsidiaries, the “Company” or “Valens”) has elected to terminate discussions for the proposed acquisition of late-stage cannabis production license (“LP”) applicant Royal Green Acres Manufacturing Ltd. (“RGAM”), and has released RGAM from the restrictions and obligations of the exclusivity period.
By Mike Rodger
Valens GroWorks (CSE:VGW)(CSE:VGW.CN) (the “Company” or “Valens”) is pleased to announce Valens Agritech Ltd. (“VAL”), a wholly owned subsidiary of the Company, has received a Dealer’s Licence pursuant to the provisions of the Controlled Drugs and Substances Act and its Regulations and will now begin operations. The issuance of the
By Pia Rivera
Valens GroWorks Corp. (CSE:VGW)(CSE:VGW.CN)(CNSX:VGW) (the “Company” or “Valens”) is pleased to announce the appointment of A.Tyler Robson, currently Chief Operating Officer and a Company director, as its new Chief Executive Officer (“CEO”) effective immediately. Rob van Santen, CEO of Valens GroWorks Corp., will remain engaged as Chief Financial Officer (“CFO”)
By Pia Rivera
Valens GroWorks Corp. (CSE:VGW)(CSE:VGW.CN) reports that it has issued a convertible unsecured note (the “Note”) to an outside director of the Company (the “Lender”), for an aggregate principal amount of $500,000.
By Pia Rivera
Valens GroWorks Corp. (CSE:VGW,CSE:VGW.CN) (the “Company” or “Valens”) is pleased to announce completion of the acquisition of Supra THC Services Inc. (“SUPRA”), a Health Canada-licensed cannabis testing lab with an established Kelowna-based scientific team supporting its operations.
Valens acquired all of the issued and outstanding shares of SUPRA for $3.75 million,
CannaRoyalty Corp. (CSE:CRZ) (OTCQB: CNNRF) is pleased to announce that it has entered into a binding term sheet (the “Term Sheet”) whereby CannaRoyalty will invest a total of US$5 million, in two tranches, in exchange for a royalty equal to 2.25% of the net sales of River Wellness Inc.
Valens GroWorks Corp. (CSE:VGW) is pleased to announce, further to its news release dated February 9, 2017, entering into a definitive share purchase agreement (the “Share Purchase Agreement”) with DHomeNest Holdings Inc. and four minority employee-shareholders (collectively, the “Vendors”) to acquire (the “Acquisition”) Supra THC Services Inc. (“Supra THC”).
Island Green Cure Ltd., its shareholders and Valens Groworks Corp. (CNSX:VGW) have jointly agreed to terminate the proposed acquisition by Valens of 80 per cent of IGC.
CannaRoyalty (CSE:CRZ)(CSE:CRZ.CN) (“CannaRoyalty” or the “Company”) is pleased to announce the closing of its previously announced acquisition of a 20% equity stake in Anandia Laboratories Inc. (“Anandia Labs”), a cutting-edge cannabis biotechnology company, in exchange for aggregate consideration of C$4,042,439.09.
Anandia Labs is the only independent Canadian testing facility specializing exclusively
Trump’s policies are affecting gold. You should know what’s going on. Click here to get our FREE report.
Click here to get your free report!Discover what the experts see coming in the Age of Trump with our INN Insider's Report free of charge! Includes expert insights into Trump and his effect on mining and gold.
